| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Mainolfi Nello is a Chief Executive Officer at Kymera Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 24 sells.
Estimated insider holdings value: $56.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2021 | KYMR Kymera Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 12,879 | $60.15 | $774,646.48 | -1.4% | -5.1% | -62.5% | |
| Jul 8, 2021 | KYMR Kymera Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 48,000 | $49.70 | $2,385,628.34 | -2.5% | +24.5% | -46.9% | |
| Jun 10, 2021 | KYMR Kymera Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 23,009 | $51.38 | $1,182,106.16 | -1.8% | +20.8% | -71.3% | |
| Jun 9, 2021 | KYMR Kymera Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 18,746 | $50.10 | $939,261.26 | -1.5% | +27.0% | -67.6% | |
| May 12, 2021 | KYMR Kymera Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 8,245 | $50.05 | $412,677.09 | -2.0% | +31.1% | -64.8% | |
| Apr 26, 2021 | KYMR Kymera Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 14,407 | $40.23 | $579,618.53 | -1.2% | +42.7% | -20.1% | |
| Apr 19, 2021 | KYMR Kymera Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 5,593 | $40.26 | $225,159.18 | -0.7% | +44.2% | -2.6% | |
| Apr 12, 2021 | KYMR Kymera Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 48,000 | $33.62 | $1,613,562.90 | -2.1% | +58.3% | +16.1% |